Armbruster Capital Management Inc. lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.4% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,396 shares of the healthcare conglomerate’s stock after buying an additional 96 shares during the quarter. Armbruster Capital Management Inc.’s holdings in UnitedHealth Group were worth $259,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. Patriot Financial Group Insurance Agency LLC raised its holdings in shares of UnitedHealth Group by 1,722.9% during the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares during the period. Kings Point Capital Management raised its holdings in shares of UnitedHealth Group by 27.9% during the 1st quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 150 shares during the period. Founders Capital Management purchased a new stake in shares of UnitedHealth Group during the 1st quarter valued at about $135,000. Parkside Financial Bank & Trust raised its holdings in shares of UnitedHealth Group by 1.4% during the 1st quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 12 shares during the period. Finally, Hanson McClain Inc. raised its holdings in shares of UnitedHealth Group by 1.7% during the 1st quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock valued at $147,000 after buying an additional 15 shares during the period. Institutional investors and hedge funds own 86.19% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2017/10/07/armbruster-capital-management-inc-has-259000-position-in-unitedhealth-group-incorporated-unh.html.

Several brokerages recently commented on UNH. Barclays PLC raised their target price on UnitedHealth Group from $200.00 to $217.00 and gave the company an “overweight” rating in a report on Wednesday, July 19th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 target price on the stock in a report on Thursday, September 21st. Cowen and Company reiterated a “buy” rating on shares of UnitedHealth Group in a report on Friday, July 14th. Leerink Swann reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Friday, June 9th. Finally, Jefferies Group LLC reiterated a “buy” rating and set a $215.00 target price on shares of UnitedHealth Group in a report on Friday, August 18th. Three analysts have rated the stock with a hold rating and twenty-three have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $203.59.

UnitedHealth Group Incorporated (NYSE UNH) opened at 198.06 on Friday. UnitedHealth Group Incorporated has a 52-week low of $133.03 and a 52-week high of $200.76. The company’s 50-day moving average price is $196.36 and its 200-day moving average price is $183.56. The firm has a market cap of $191.50 billion, a price-to-earnings ratio of 23.79 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. During the same period in the prior year, the firm posted $1.96 EPS. UnitedHealth Group’s quarterly revenue was up 7.7% compared to the same quarter last year. Analysts predict that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th were issued a $0.75 dividend. The ex-dividend date was Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.51%. UnitedHealth Group’s payout ratio is presently 35.13%.

In other news, Director Richard T. Burke sold 15,000 shares of the stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $191.71, for a total value of $2,875,650.00. Following the completion of the transaction, the director now directly owns 1,818,898 shares of the company’s stock, valued at approximately $348,700,935.58. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total value of $969,900.00. Following the completion of the transaction, the director now directly owns 76,058 shares of the company’s stock, valued at $14,753,730.84. The disclosure for this sale can be found here. Over the last three months, insiders sold 76,174 shares of company stock valued at $14,981,909. 0.89% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.